The 2023 China Pharmaceutical Industry Development Conference press conference was held on the morning of the 24th. The press conference announced that the 2023 China Pharmaceutical Industry Development Conference will be held in Beijing from November 17th to 19th. This conference will fully demonstrate the latest technologies, latest achievements, and latest applications in China's pharmaceutical industry, and comprehensively explore the development trends of the pharmaceutical industry.
At the press conference, He Yaqiong, Director of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology, introduced that this conference will have the theme of "Gathering development forces to build a solid foundation for health" to comprehensively demonstrate the Chinese pharmaceutical industry's achievements in chemical drugs, traditional Chinese medicines, and biological drugs. , medical device manufacturing and other aspects have achieved outstanding results and comprehensive capabilities, create an international, high-end, professional exchange and cooperation platform, and jointly promote the high-quality development of China's pharmaceutical industry to a new level.
According to reports, the conference will last for three days, with the opening ceremony and main forum held on November 17; a series of 16 special meetings will be held from the 18th to the 19th, focusing on strengthening technological innovation, enhancing the competitiveness of the industrial chain, and improving supply The main features of the conference include the following aspects:
First, focus on the pharmaceutical industry. The conference focused more on promoting high-quality development of the pharmaceutical industry, interpreting and communicating from a manufacturing perspective. The five departments of the Ministry of Industry and Information Technology, the National Health Commission, the State-owned Assets Supervision and Administration Commission of the State Council, the State Administration of Traditional Chinese Medicine, and the State Food and Drug Administration that co-sponsored the conference are responsible for promoting the high-quality development of the pharmaceutical industry; Beijing is the largest pharmaceutical industry in the country. It is an innovation highland and plays an important role in demonstrating and leading the country. I believe that through the joint efforts of the six organizers, this conference will definitely achieve greater effectiveness in promoting the high-quality development of the pharmaceutical industry.
The second is to strengthen dialogue and exchanges. The conference has a large number of organizers and a wide range of functions. It will benchmark against top domestic and foreign forums and is committed to building the conference into an international, high-end and professional industry discussion platform. Relevant leaders, top experts and scholars at home and abroad, and heads of well-known pharmaceutical companies and other important guests will be invited to gather together to exchange ideas and build consensus in dialogue.
The third is to create an industrial ecosystem. The conference will not only cover sub-industries such as chemical drugs, traditional Chinese medicines, biopharmaceuticals, and medical devices, but also involve all upstream and downstream links in the industrial chain, organizing all parties in the entire industrial chain and ecosystem to speak out on the same stage, and continuously expand the "innovation and development of the pharmaceutical industry" to promote innovation and development. "Friends Circle", working together to promote the high-quality development of the pharmaceutical industry.
Fourth, fruitful results have been achieved. The conference will organize expert interpretations, round-table discussions and other activities to in-depth publicize and implement the "14th Five-Year Plan for the Development of the Pharmaceutical Industry" and the "14th Five-Year Plan for the Development of the Medical Equipment Industry", and create a platform for the release and publicity of policies and measures related to the pharmaceutical industry. An important platform to promote the implementation of various deployments. The conference will also release relevant policies for the "Beijing-Tianjin-Hebei Medical and Health Industry Cluster", hold a signing ceremony for the co-construction of the "Pharmaceutical Industry Chain Research Institute", and release relevant industry research reports and white papers in the pharmaceutical industry.
微信扫一扫打赏
